Sionna Therapeutics, Inc.

SION · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
Operating Activities
Net Income-$61,688-$47,263-$40,240
Dep. & Amort.$668$583$122
Deferred Tax$0$0$0
Stock-Based Comp.$3,708$2,259$1,686
Change in WC-$3,075-$783$2,764
Other Non-Cash$7,600$1,505-$400
Operating Cash Flow-$52,787-$43,699-$36,068
Investing Activities
PP&E Inv.-$27-$1,116-$1,874
Net Acquisitions$0$0$0
Inv. Purchases-$182,841-$23,532-$40,389
Inv. Sales/Matur.$55,955$52,000$13,000
Other Inv. Act.$0$0$0
Investing Cash Flow-$126,913$27,352-$29,263
Financing Activities
Debt Repay.$0$0$0
Stock Issued$178,967$0$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0$31$110,855
Financing Cash Flow$178,967$31$110,855
Forex Effect$0$0$0
Net Chg. in Cash-$733-$16,316$45,524
Supplemental Information
Beg. Cash$39,483$55,799$10,275
End Cash$38,750$39,483$55,799
Free Cash Flow-$52,814-$44,815-$37,942